(Q36302325)

13 August 2017

1 reference

title

Opinion: antibody-based therapies for malaria (English)

1 reference

13 August 2017

0 references

1 reference

Richard J Pleass

1

1 reference

13 August 2017

Anthony A Holder

series ordinal

2

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

Nature Reviews Microbiology

13 August 2017

1 reference

13 August 2017

3

1 reference

13 August 2017

893-899

1 reference

13 August 2017

11

1 reference

https://scigraph.springernature.com/pub.10.1038/nrmicro1267

13 August 2017

0 references

cites work

The global distribution of clinical episodes of Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Genome sequence of the human malaria parasite Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Gamma-globulin and acquired immunity to human malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 1 of the malaria parasite Plasmodium falciparum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Antibody- and Fc-receptor-based therapeutics for malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Antibody-mediated regulation of cellular immunity and the inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Pattern recognition molecules and innate immunity to parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Human malaria in immunocompromised mice: an in vivo model to study defense mechanisms against Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

A role for B cells in the development of T cell helper function in a malaria infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Novel antimalarial antibodies highlight the importance of the antibody Fc region in mediating protection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Role of nonimmune IgG bound to PfEMP1 in placental malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

A robust neutralization test for Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Elevated anti-malarial IgE in asymptomatic individuals is associated with reduced risk for subsequent clinical malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Nonspecific immunoglobulin M binding and chondroitin sulfate A binding are linked phenotypes of Plasmodium falciparum isolates implicated in malaria during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Specific monoclonal IgM is a potent adjuvant in murine malaria vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Natural antibodies and complement are endogenous adjuvants for vaccine-induced CD8+ T-cell responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Inhibitory factors in breastmilk, maternal and infant sera against in vitro growth of Plasmodium falciparum malaria parasite

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Immature neutrophils mediate tumor cell killing via IgA but not IgG Fc receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Pathways and strategies for developing a malaria blood-stage vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Functional conservation of the malaria vaccine antigen MSP-119across distantly related Plasmodium species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Antibodies against merozoite surface protein (MSP)-1(19) are a major component of the invasion-inhibitory response in individuals immune to malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

A genetic approach to the de novo identification of targets of strain-specific immunity in malaria parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Inhibitory and neutral antibodies to Plasmodium falciparum MSP119 form ring structures with their antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Precise epitope mapping of malaria parasite inhibitory antibodies by TROSY NMR cross-saturation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Malaria parasite-inhibitory antibody epitopes on Plasmodium falciparum merozoite surface protein-1(19) mapped by TROSY NMR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Vaccination of monkeys with recombinant Plasmodium falciparum apical membrane antigen 1 confers protection against blood-stage malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

High-level expression of the malaria blood-stage vaccine candidate Plasmodium falciparum apical membrane antigen 1 and induction of antibodies that inhibit erythrocyte invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Antibody reactivity to conserved linear epitopes of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

T-cell activation and cytokine production via a bispecific single-chain antibody fragment targeted to blood-stage malaria parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Antibody humanization: a case of the 'Emperor's new clothes'?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Antibodies from phage antibody libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Prokaryotic expression of antibodies and affibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Yeast display of antibody fragments: a discovery and characterization platform.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Antibody engineering via genetic engineering of the mouse: XenoMouse strains are a vehicle for the facile generation of therapeutic human monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Functional heavy-chain antibodies in Camelidae

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Crystal structure of a shark single-domain antibody V region in complex with lysozyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

The antiviral activity of antibodies in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Antibodies inhibit prion propagation and clear cell cultures of prion infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Selection and affinity maturation of IgNAR variable domains targeting Plasmodium falciparum AMA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Human CD14 is an efficient target for recombinant immunoglobulin vaccine constructs that deliver T cell epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

21 January 2018

Engineered antibodies

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Engineered antibody fragments and the rise of single domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

ALTERATIONS IN SERUM PROTEINS AND 19S ANTIBODY PRODUCTION DURING THE COURSE OF INDUCED MALARIAL INFECTIONS IN MAN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Introduction: bispecific antibodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Induction of a long-lasting antitumor immunity by a trifunctional bispecific antibody

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

Molecular basis of Fc receptor function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

inferred from DOI database lookup

7 January 2021

based on heuristic

A malaria merozoite surface protein (MSP1)-structure, processing and function

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1267

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRMICRO1267

1 reference

Dimensions Publication ID

13 August 2017

0 references

1 reference